
简介:
- 作者: Ting Lan, Huangyao Chen, Chengcheng Tang, Yuhui Wei, Yang Liu, Jizeng Zhou, Zhenpeng Zhuang, Quanjun Zhang, Min Chen, Xiaoqing Zhou, Yue Chi, Jinling Wang, Yu He, Liangxue Lai, and Qingjian Zou
- 杂志: Mol Ther Nucleic Acids
- Doi: https://www.doi.org/10.1016/j.omtn.2023.08.018
- 出版日期: 2023 Aug 17
论文中使用的产品/服务
Quotation shows PackGene:AAV9 was packaged by PackGene Biotech Co., Ltd.
Research Field:gene editing; eye
AAV Serotype:AAV9
Targeted organ:eye
Animal or cell line strain:the two-week-old mice
摘要
Prime editor (PE) is a versatile genome-editing tool without needing extra DNA donors or inducing double-strand breaks. However, in vivo implementation of PE remains challenge because of its oversized composition. In this study, we screened out the smallest truncated Moloney-murine leukemia virus reverse transcriptase (M-MLV RT) with F155Y mutation to keep gene editing efficiency. The truncated M-MLV RT variant was further fused with Campylobacter jejuni Cas9 (CjCas9, H559A) to construct a mini-PE system with a reduced gene size (4.5 kb) right in the packaging capacity of adeno-associated virus. After optimizing of the pegRNAs and incorporating with nick sgRNAs, the mini-PE delivered up to 10% precise editing at target sites in human and mouse cells. It also edited mouse Hsf1 gene in mouse retina precisely after delivered with AAVs, although the editing efficiency was lower than 1%. We will focus on improving the editing efficiency of mini-PE, and exploiting it therapeutic potential against human genetic diseases.
关于派真
作为一家专注于AAV 技术十余年,深耕基因治疗领域的CRO&CDMO,派真生物可提供从载体设计、构建到 AAV、慢病毒和 mRNA 服务的一站式解决方案。凭借深厚的技术实力、卓越的运营管理和高标准的服务交付,我们为全球客户提供一站式CMC解决方案,包括从早期概念验证、成药性评估到IIT、IND及BLA的各个阶段。
凭借我们独立知识产权的π-alphaTM 293 细胞AAV高产技术平台,我们能将AAV产量提高多至10倍,每批次产量可达1×10¹⁷vg,以满足多样化的商业化和临床项目需求。此外,我们定制化的mRNA和脂质纳米颗粒(LNP)产品及服务覆盖药物和疫苗开发的各个阶段,从研发到符合GMP的生产,提供端到端的一站式解决方案。
